Ayurvedic medicine to treat dengue to be launched by 2021: AYUSH Ministry

Published On 2019-10-05 03:55 GMT   |   Update On 2020-01-08 14:06 GMT

New Delhi: An ayurvedic medicine to treat dengue is undergoing the third and final phase of clinical trials and will be launched within the next two years, a senior official of the Ayush Ministry said. Ayush Secretary Vaidya Rajesh Kotecha said the research on this was being carried out by Ayush (Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa Rigpa and Homoeopathy) Ministry and the Indian Council of Medical Research (ICMR).


It is made of a variety of ayurvedic herbs grown in India and is likely to hit the market within the next two years in the form of a pill.


"The research is in the third phase (final phase) of clinical trial. It will be done in the next two years. Once finished, this will be the world's first medicine against dengue," he said on the sidelines of a press conference on the achievements of the ministry in the last 100 days.


Read Also: Dengue vaccination to be launched in India; demo in next year: ICMR


Details, such as the name of the medicine, how it will be sold - over the counter or through prescription - are yet to be decided. The ICMR and the ministry team will also have to work to standardise the dosage and fix the proportion of each herb used.


Read Also: Malaria, Dengue notifiable diseases: Dr Harsh Vardhan urges City Govt, Municipal Corporations to make Delhi Vector free

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News